PPSV 23 Vaccine
The Pneumococcal Polysaccharide Vaccine (PPSV23) is recommended by the Indian Academy of Pediatrics (IAP) to protect against pneumococcal diseases caused by 23 types of pneumococcal bacteria. Pneumococcal diseases can range from ear and sinus infections to pneumonia, meningitis, and bacteremia (blood infection), particularly in certain high-risk groups. Here’s an overview of the IAP guidelines for the PPSV23 vaccine:
Understanding Pneumococcal Diseases
-
Disease Overview: Caused by the bacterium Streptococcus pneumoniae, leading to a range of illnesses, some of which can be life-threatening.
-
Risk Groups: Particularly dangerous for people with certain health conditions, the elderly, and those with compromised immune systems.
PPSV23 Vaccine
Purpose: To prevent infections caused by 23 types of Streptococcus pneumoniae.
Target Groups: Recommended for high-risk groups and older adults.
Target Groups: Recommended for high-risk groups and older adults.
IAP Recommended Schedule for PPSV23 Vaccination
Target Groups:
– Adults aged 65 years and older.
– Individuals aged 2 years and older with certain chronic health conditions, such as chronic heart, lung, or liver diseases, diabetes, or alcoholism.
– Individuals with a weakened immune system, including those with HIV/AIDS, cancer, or who have had an organ transplant.
– Individuals with cochlear implants or cerebrospinal fluid leaks.
Vaccination Schedule:
– Single Dose: Generally, a single dose of PPSV23 is recommended for these groups.
– Revaccination: A second dose of PPSV23 may be given 5 years after the first dose to individuals aged 65 and older who received their first dose when they were younger than 65, as well as to people at highest risk for serious pneumococcal infection.
– Children Under 2 Years: PPSV23 is not recommended for children under 2 years; they should receive the pneumococcal conjugate vaccine (PCV) instead.
– Adults aged 65 years and older.
– Individuals aged 2 years and older with certain chronic health conditions, such as chronic heart, lung, or liver diseases, diabetes, or alcoholism.
– Individuals with a weakened immune system, including those with HIV/AIDS, cancer, or who have had an organ transplant.
– Individuals with cochlear implants or cerebrospinal fluid leaks.
Vaccination Schedule:
– Single Dose: Generally, a single dose of PPSV23 is recommended for these groups.
– Revaccination: A second dose of PPSV23 may be given 5 years after the first dose to individuals aged 65 and older who received their first dose when they were younger than 65, as well as to people at highest risk for serious pneumococcal infection.
– Children Under 2 Years: PPSV23 is not recommended for children under 2 years; they should receive the pneumococcal conjugate vaccine (PCV) instead.
Vaccine Administration
Method: The vaccine is administered as an intramuscular or subcutaneous injection.
Safety and Side Effects
Common Side Effects: Pain at the injection site, mild fever, and muscle aches.
Serious Side Effects: Rare, but may include allergic reactions.
Serious Side Effects: Rare, but may include allergic reactions.
Who Should Receive the Vaccine
Recommended for the specific high-risk groups mentioned above.
Who Should Not Receive the Vaccine
– Individuals with a known severe allergic reaction to any component of the PPSV23 vaccine.
– Those with a severe allergy to any vaccine containing diphtheria toxoid.
– Those with a severe allergy to any vaccine containing diphtheria toxoid.
Importance in Public Health
PPSV23 plays a crucial role in preventing pneumococcal diseases in high-risk populations.
Consultation with Healthcare Professionals
Consultation with a healthcare provider is essential for personalized advice and to determine if the vaccine is appropriate based on individual risk factors.
Disclaimer
-
This information is for educational purposes only and may not reflect the most current data available. Always consult a pediatrician or healthcare professional for medical advice and before making any vaccination decisions. We strive to keep this information updated, but it may not be updated in real time
-
Consultation with healthcare professionals is essential for personalized advice and to address specific health concerns.
CALL +91 96060 77401 to schedule the appointment today
Contact us
Call us
+91 96060 77401
Visit us at
Aloha Kids Clinic
No 531, 2nd Floor,
Nammalaya Building
Doddakallasandra,
Bangalore – 560062
Send us an email
admin@alohakidsclinic.com
About us
Subscribe
Sign up for the Aloha newsletter to receive all the news offers and discounts from the Aloha Kids clinic.
Contact us
Call us
+91 96060 77401
Visit us at
Aloha Kids Clinic
No 531, 2nd Floor,
Nammalaya Building,
Doddakallasandra,
Bangalore – 560062
Send us an email
admin@alohakidsclinic.com
About us
Subscribe
Sign up for the Aloha newsletter to receive all the news offers and discounts from Aloha Kids clinic.
Copyright by Aloha Kids Clinic,2023. All rights reserved.
Copyright by Aloha kids clinic,2023 All rights reserved.